|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Paez JG, Jänne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kwak EL, Bang YJ, Camidge DR, et al:
Anaplastic lymphoma kinase inhibition in non-small-cell lung
cancer. N Engl J Med. 363:1693–1703. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Davies JJ, Wilson IM and Lam WL: Array CGH
technologies and their applications to cancer genomes. Chromosome
Res. 13:237–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
de Leeuw RJ, Davies JJ, Rosenwald A, et
al: Comprehensive whole genome array CGH profiling of mantle cell
lymphoma model genomes. Hum Mol Genet. 13:1827–1837.
2004.PubMed/NCBI
|
|
6.
|
Nakao K, Mehta KR, Fridlyand J, et al:
High-resolution analysis of DNA copy number alterations in
colorectal cancer by array-based comparative genomic hybridization.
Carcinogenesis. 25:1345–1357. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Wong MP, Fung LF, Wang E, et al:
Chromosomal aberrations of primary lung adenocarcinomas in
nonsmokers. Cancer. 97:1263–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Zhu H, Lam DC, Han KC, et al: High
resolution analysis of genomic aberrations by metaphase and array
comparative genomic hybridization identifies candidate tumour genes
in lung cancer cell lines. Cancer Lett. 245:303–314. 2007.
View Article : Google Scholar
|
|
9.
|
Lan Q, Hsiung CA, Matsuo K, et al:
Genome-wide association analysis identifies new lung cancer
susceptibility loci in never-smoking women in Asia. Nat Genet.
44:1330–1335. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hsiung CA, Lan Q, Hong YC, et al: The
5p15.33 locus is associated with risk of lung adenocarcinoma in
never-smoking females in Asia. PLoS Genet. 6:e10010512010.
View Article : Google Scholar
|
|
11.
|
McKay JD, Hung RJ, Gaborieau V, et al:
Lung cancer susceptibility locus at 5p15.33. Nat Genet.
40:1404–1406. 2008. View
Article : Google Scholar
|
|
12.
|
Wang Y, Broderick P, Webb E, et al: Common
5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet.
40:1407–1409. 2008. View
Article : Google Scholar
|
|
13.
|
Dong J, Hu Z, Wu C, et al: Association
analyses identify multiple new lung cancer susceptibility loci and
their interactions with smoking in the Chinese population. Nat
Genet. 44:895–899. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Fan B, Dachrut S, Coral H, et al:
Integration of DNA copy number alterations and transcriptional
expression analysis in human gastric cancer. PLoS One.
7:e298242012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Holzmann K, Kohlhammer H, Schwaenen C, et
al: Genomic DNA-chip hybridization reveals a higher incidence of
genomic amplifications in pancreatic cancer than conventional
comparative genomic hybridization and leads to the identification
of novel candidate genes. Cancer Res. 64:4428–4433. 2004.
View Article : Google Scholar
|
|
16.
|
Tonon G, Wong KK, Maulik G, et al:
High-resolution genomic profiles of human lung cancer. Proc Natl
Acad Sci USA. 102:9625–9630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kim TM, Yim SH, Lee JS, et al: Genome-wide
screening of genomic alterations and their clinicopathologic
implications in non-small cell lung cancers. Clin Cancer Res.
11:8235–8242. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Shibata T, Uryu S, Kokubu A, et al:
Genetic classification of lung adenocarcinoma based on array-based
comparative genomic hybridization analysis: its association with
clinicopathologic features. Clin Cancer Res. 11:6177–6185. 2005.
View Article : Google Scholar
|
|
19.
|
Rácz A, Brass N, Höfer M, Sybrecht GW,
Remberger K and Meese EU: Gene amplification at chromosome
1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung
carcinoma. Int J Oncol. 17:67–73. 2000.PubMed/NCBI
|
|
20.
|
Xu X, Padilla MT, Li B, et al: MUC1 in
macrophage: contributions to cigarette smoke-induced lung cancer.
Cancer Res. 74:460–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Yan C, Ding X, Wu L, Yu M, Qu P and Du H:
Stat3 downstream gene product chitinase 3-like 1 is a potential
biomarker of inflammation-induced lung cancer in multiple mouse
lung tumor models and humans. PLoS One. 8:e619842013. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Aras G, Kanmaz D, Urer N, Purisa S,
Kadakal F, Yentürk E and Tuncay E: Immunohistochemical expression
of telomerase in patients with non-small cell lung cancer:
prediction of metastasis and prognostic significance. Anticancer
Res. 33:2643–2650. 2013.PubMed/NCBI
|
|
23.
|
Lantuéjoul S, Salon C, Soria JC and
Brambilla E: Telomerase expression in lung preneoplasia and
neoplasia. Int J Cancer. 120:1835–1841. 2007.
|
|
24.
|
Pizzi M, Fassan M, Balistreri M,
Galligioni A, Rea F and Rugge M: Anterior gradient 2 overexpression
in lung adenocarcinoma. Appl Immunohistochem Mol Morphol. 20:31–36.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Larue L and Delmas V: The WNT/Beta-catenin
pathway in melanoma. Front Biosci. 11:733–742. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Zhou XL, Qin XR, Zhang XD and Ye LH:
Downregulation of Dickkopf-1 is responsible for high proliferation
of breast cancer cells via losing control of Wnt/β-catenin
signaling. Acta Pharmacol Sin. 31:202–210. 2010.PubMed/NCBI
|
|
27.
|
Gautschi O, Ratschiller D, Gugger M,
Betticher DC and Heighway J: Cyclin D1 in non-small cell lung
cancer: a key driver of malignant transformation. Lung Cancer.
55:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Gee JM, Eloranta JJ, Ibbitt JC, et al:
Overexpression of TFAP2C in invasive breast cancer correlates with
a poorer response to anti-hormone therapy and reduced patient
survival. J Pathol. 217:32–41. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lee MH and Surh YJ: eFF1A2 as a putative
oncogene. Ann NY Acad Sci. 1171:87–93. 2009. View Article : Google Scholar
|
